Evidence map›Paper›PMID 22710563›Full record

Trial reportContemporary clinical trials2012

Peer education for secondary stroke prevention in inner-city minorities: design and methods of the prevent recurrence of all inner-city strokes through education randomized controlled trial.

Judith Z Goldfinger, Ian M Kronish, Kezhen Fei, Albert Graciani, Peri Rosenfeld, Kate Lorig, Carol R Horowitz

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01027273 (Preventing Recurrence of All Inner-city Strokes Through Education), which is not on this map. Cited by 26 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 7 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01027273 nacompletednot on this map

Preventing Recurrence of All Inner-city Strokes Through Education

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2009 to 2013Enrolled600ConditionsStroke Recurrence, Transient Ischemic AttackArmsPrevent Return of Stroke
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 7 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Life after Stroke in an Urban Minority Population: A Photovoice Project.International journal of environmental research and public health · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Judith Z GoldfingerDepartment of Health Evidence and Policy, Mount Sinai School of Medicine, New York, NY, USA. Judith.Goldfinger@mountsinai.org
Ian M Kronish
Kezhen Fei
Albert Graciani
Peri Rosenfeld
Kate Lorig
Carol R Horowitz
Icahn School of Medicine at Mount Sinai · USColumbia University Irving Medical Center · USHarlem United · USStanford University · USVisiting Nurse Service of New York · US

Funding

MOUNT SINAI INSTITUTES FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR029887 · NCRR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2009 to 2011
$19.2M
RESEARCH COREP60MD000270 · NIMHD · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BICKELL, NINA A. · 2002 to 2011
$15.1M
Uncontrolled hypertension - the role of medication adherence and clinical inertiaK23HL098359 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRONISH, IAN MATTHEW · 2010 to 2014
$688k
NCRR NIH HHS UL1 RR029887NCRR NIH HHS UL1RR029887NHLBI NIH HHS K23 HL098359NIMHD NIH HHS 5P60MD000270NIMHD NIH HHS P60 MD000270
6 · The paper itself

Abstract

backgroundThe highest risk for stroke is among survivors of strokes or transient ischemic attacks (TIA). However, use of proven-effective cardiovascular medications to control stroke risk is suboptimal, particularly among the Black and Latino populations disproportionately impacted by stroke.

methodsA partnership of Harlem and Bronx community representatives, stroke survivors, researchers, clinicians, outreach workers and patient educators used community-based participatory research to conceive and develop the Prevent Recurrence of All Inner-city Strokes through Education (PRAISE) trial. Using data from focus groups with stroke survivors, they tailored a peer-led, community-based chronic disease self-management program to address stroke risk factors. PRAISE will test, in a randomized controlled trial, whether this stroke education intervention improves blood pressure control and a composite outcome of blood pressure control, lipid control, and use of antithrombotic medications.

resultsOf the 582 survivors of stroke and TIA enrolled thus far, 81% are Black or Latino and 56% have an annual income less than $15,000. Many (33%) do not have blood pressures in the target range, and most (66%) do not have control of all three major stroke risk factors.

conclusionsRates of stroke recurrence risk factors remain suboptimal in the high risk, urban, predominantly minority communities studied. With a community-partnered approach, PRAISE has recruited a large number of stroke and TIA survivors to date, and may prove successful in engaging those at highest risk for stroke and reducing disparities in stroke outcomes in inner-city communities.

Indexed as

Urban PopulationAntihypertensive AgentsBlack or African AmericanBlood PressureCommunity-Based Participatory ResearchFibrinolytic AgentsHispanic or LatinoHumansHypolipidemic AgentsIschemic Attack, TransientLipidsNew York CityPatient Education as TopicRandomized Controlled Trials as TopicRecurrenceRisk FactorsAntihypertensive AgentsFibrinolytic AgentsHypolipidemic AgentsLipids

Identifiers

PMID22710563
PMCPMC3408803
OpenAlexW2033877215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.